| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1246269
[patent_doc_number] => 06677443
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-13
[patent_title] => 'Insect monoamine transporter and methods of use thereof'
[patent_app_type] => B1
[patent_app_number] => 09/587811
[patent_app_country] => US
[patent_app_date] => 2000-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13926
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/677/06677443.pdf
[firstpage_image] =>[orig_patent_app_number] => 09587811
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/587811 | Insect monoamine transporter and methods of use thereof | Jun 5, 2000 | Issued |
| 09/584555 | Method of reducing injury to mammalian cells | May 30, 2000 | Abandoned |
Array
(
[id] => 1181027
[patent_doc_number] => 06740735
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-25
[patent_title] => 'DNA encoding human apoB48R: a monocyte-macrophage apolipoprotein B48 receptor gene and protein'
[patent_app_type] => B1
[patent_app_number] => 09/583610
[patent_app_country] => US
[patent_app_date] => 2000-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 42
[patent_no_of_words] => 31434
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/740/06740735.pdf
[firstpage_image] =>[orig_patent_app_number] => 09583610
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/583610 | DNA encoding human apoB48R: a monocyte-macrophage apolipoprotein B48 receptor gene and protein | May 30, 2000 | Issued |
Array
(
[id] => 1508398
[patent_doc_number] => 06441136
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-27
[patent_title] => 'Site specific protein modification'
[patent_app_type] => B1
[patent_app_number] => 09/580181
[patent_app_country] => US
[patent_app_date] => 2000-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11164
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/441/06441136.pdf
[firstpage_image] =>[orig_patent_app_number] => 09580181
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/580181 | Site specific protein modification | May 25, 2000 | Issued |
Array
(
[id] => 1602979
[patent_doc_number] => 06433158
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-13
[patent_title] => 'Site specific protein modification'
[patent_app_type] => B1
[patent_app_number] => 09/580235
[patent_app_country] => US
[patent_app_date] => 2000-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11162
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/433/06433158.pdf
[firstpage_image] =>[orig_patent_app_number] => 09580235
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/580235 | Site specific protein modification | May 25, 2000 | Issued |
Array
(
[id] => 1365555
[patent_doc_number] => 06569997
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-27
[patent_title] => 'Antibody specific for H4-1BB'
[patent_app_type] => B1
[patent_app_number] => 09/578764
[patent_app_country] => US
[patent_app_date] => 2000-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 8
[patent_no_of_words] => 23382
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/569/06569997.pdf
[firstpage_image] =>[orig_patent_app_number] => 09578764
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/578764 | Antibody specific for H4-1BB | May 24, 2000 | Issued |
| 09/463629 | PHARMACEUTICALS FOR MODULATING HORMONE RESPONSIVENESS | May 10, 2000 | Abandoned |
Array
(
[id] => 1024708
[patent_doc_number] => 06884770
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-04-26
[patent_title] => 'Methods and compositions for treating or preventing peripheral neuropathies'
[patent_app_type] => utility
[patent_app_number] => 09/569386
[patent_app_country] => US
[patent_app_date] => 2000-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 36
[patent_no_of_words] => 35551
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/884/06884770.pdf
[firstpage_image] =>[orig_patent_app_number] => 09569386
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/569386 | Methods and compositions for treating or preventing peripheral neuropathies | May 10, 2000 | Issued |
Array
(
[id] => 1361718
[patent_doc_number] => 06573366
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-03
[patent_title] => 'Process for the purification of human interleukin-1 receptor antagonist from recombinant E. coli'
[patent_app_type] => B1
[patent_app_number] => 09/568202
[patent_app_country] => US
[patent_app_date] => 2000-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3387
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/573/06573366.pdf
[firstpage_image] =>[orig_patent_app_number] => 09568202
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/568202 | Process for the purification of human interleukin-1 receptor antagonist from recombinant E. coli | May 8, 2000 | Issued |
Array
(
[id] => 1180331
[patent_doc_number] => 06737242
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-18
[patent_title] => 'Methods for screening GABA-modulatory compounds for specified pharmacological activities'
[patent_app_type] => B1
[patent_app_number] => 09/565524
[patent_app_country] => US
[patent_app_date] => 2000-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13724
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/737/06737242.pdf
[firstpage_image] =>[orig_patent_app_number] => 09565524
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/565524 | Methods for screening GABA-modulatory compounds for specified pharmacological activities | May 4, 2000 | Issued |
Array
(
[id] => 1286774
[patent_doc_number] => 06635432
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-21
[patent_title] => 'Peptide potentiation of acid-sensory ion channel in pain'
[patent_app_type] => B1
[patent_app_number] => 09/557506
[patent_app_country] => US
[patent_app_date] => 2000-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 26
[patent_no_of_words] => 8526
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/635/06635432.pdf
[firstpage_image] =>[orig_patent_app_number] => 09557506
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/557506 | Peptide potentiation of acid-sensory ion channel in pain | Apr 24, 2000 | Issued |
Array
(
[id] => 4274998
[patent_doc_number] => 06323333
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-27
[patent_title] => 'Mouse EDG1'
[patent_app_type] => 1
[patent_app_number] => 9/542733
[patent_app_country] => US
[patent_app_date] => 2000-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11056
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/323/06323333.pdf
[firstpage_image] =>[orig_patent_app_number] => 542733
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/542733 | Mouse EDG1 | Apr 3, 2000 | Issued |
Array
(
[id] => 1179512
[patent_doc_number] => 06740500
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-25
[patent_title] => 'Method of screening for non-steroidal neuropsychiatric agents'
[patent_app_type] => B1
[patent_app_number] => 09/534831
[patent_app_country] => US
[patent_app_date] => 2000-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 3088
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/740/06740500.pdf
[firstpage_image] =>[orig_patent_app_number] => 09534831
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/534831 | Method of screening for non-steroidal neuropsychiatric agents | Mar 22, 2000 | Issued |
Array
(
[id] => 1188751
[patent_doc_number] => 06733982
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-05-11
[patent_title] => 'Method for screening compounds for alpha1B adrenergic receptor antagonist and analgesic activity'
[patent_app_type] => B1
[patent_app_number] => 09/520584
[patent_app_country] => US
[patent_app_date] => 2000-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13534
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/733/06733982.pdf
[firstpage_image] =>[orig_patent_app_number] => 09520584
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/520584 | Method for screening compounds for alpha1B adrenergic receptor antagonist and analgesic activity | Mar 7, 2000 | Issued |
Array
(
[id] => 616584
[patent_doc_number] => 07144996
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-12-05
[patent_title] => 'Nucleic acid encoding human suppressor of fused'
[patent_app_type] => utility
[patent_app_number] => 09/581742
[patent_app_country] => US
[patent_app_date] => 2000-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 29
[patent_no_of_words] => 34167
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/144/07144996.pdf
[firstpage_image] =>[orig_patent_app_number] => 09581742
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/581742 | Nucleic acid encoding human suppressor of fused | Mar 1, 2000 | Issued |
Array
(
[id] => 1517982
[patent_doc_number] => 06500941
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-31
[patent_title] => 'Gamma-heregulin'
[patent_app_type] => B1
[patent_app_number] => 09/514573
[patent_app_country] => US
[patent_app_date] => 2000-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 16
[patent_no_of_words] => 28394
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/500/06500941.pdf
[firstpage_image] =>[orig_patent_app_number] => 09514573
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/514573 | Gamma-heregulin | Feb 27, 2000 | Issued |
Array
(
[id] => 1573835
[patent_doc_number] => 06468533
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-22
[patent_title] => 'Antagonists of HMG1 for treating inflammatory conditions'
[patent_app_type] => B1
[patent_app_number] => 09/503632
[patent_app_country] => US
[patent_app_date] => 2000-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8022
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/468/06468533.pdf
[firstpage_image] =>[orig_patent_app_number] => 09503632
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/503632 | Antagonists of HMG1 for treating inflammatory conditions | Feb 13, 2000 | Issued |
| 09/501787 | Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the CNS | Feb 10, 2000 | Abandoned |
Array
(
[id] => 1253821
[patent_doc_number] => 06670465
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-30
[patent_title] => 'Retinal calcium channel (alpha)1F-subunit gene'
[patent_app_type] => B1
[patent_app_number] => 09/495714
[patent_app_country] => US
[patent_app_date] => 2000-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 18804
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/670/06670465.pdf
[firstpage_image] =>[orig_patent_app_number] => 09495714
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/495714 | Retinal calcium channel (alpha)1F-subunit gene | Jan 31, 2000 | Issued |
| 09/492375 | 7TM receptor axor51 | Jan 26, 2000 | Abandoned |